A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors
Clinical trial NCT02133625 · COMPLETED
Trial details
- NCT number
- NCT02133625
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2016-03-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.